Randomized Clinical Trial for the Prevention of Cognitive Impairment in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics
- Acronyms GIRAF
- 24 Oct 2017 Planned End Date changed from 1 May 2018 to 1 Oct 2018.
- 24 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated